XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics
New York – November 21, 2025 – Cooley acted as the US legal advisor to LAVA Therapeutics, a Dutch biopharmaceutical company that has developed several clinical-stage bispecific gamma delta T cell engagers using its proprietary Gammabody platform, on its acquisition by XOMA Royalty.
LAVA shareholders received $1.04 in cash per share and a nontransferrable contingent value right (CVR) per share representing the right to receive certain cash payments, including the right to receive, among other things, 75% of any net proceeds related to LAVA’s two partnered assets, plus 75% of any net proceeds from any out-license or sale of LAVA’s unpartnered programs, and the right to receive up to approximately $0.23 per CVR depending on the final determination after closing of certain potential liabilities.
Lawyers Rita Sobral, Katie Kazem, Div Gupta, Kevin Cooper, Courtney Thorne, Jeffrey Tolin, Barbara Mirza, Sydney Sawyier, Trevor Bossi, Melanie Simon-Giblin, Danbi Kim and Chelsea Braun led the Cooley team serving as US legal advisor to LAVA.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.
Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.